Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NJ Bio is a private contract research, development, and manufacturing organization focused on integrated chemistry and biology services for biotech and pharmaceutical clients. The company is best known for expertise in antibody-drug conjugates, bioconjugation, payload-linker chemistry, oligonucleotides, mRNA, protein degraders, analytical testing, and GMP manufacturing support. NJ Bio operates from Princeton, New Jersey, with additional chemistry operations in Bristol, Pennsylvania and Mumbai, India. Rather than advancing a proprietary therapeutic pipeline, it provides fee-for-service discovery, development, translational research, and early clinical manufacturing capabilities. The company has positioned itself as a specialist partner for complex conjugates and advanced therapeutics, particularly ADCs and related bioconjugates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NJ Bio.